Clough Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-129,503
Closed -$16M 143
2024
Q2
$16M Buy
129,503
+11,238
+10% +$1.45M 1.75% 15
2024
Q1
$15.6M Sell
118,265
-4,688
-4% -$578K 1.72% 15
2023
Q4
$13.4M Sell
122,953
-10,697
-8% -$1.11M 1.48% 21
2023
Q3
$13.8M Buy
133,650
+25,010
+23% +$2.7M 1.48% 20
2023
Q2
$12.5M Buy
108,640
+9,790
+10% +$1.11M 1.26% 21
2023
Q1
$10.5M Buy
98,850
+49,460
+100% +$5.34M 1.13% 29
2022
Q4
$5.48M Buy
+49,390
New +$5.05M 0.56% 63
2022
Q2
Sell
-220,300
Closed -$18.1M 112
2022
Q1
$18.1M Sell
220,300
-44,200
-17% -$3.48M 1.37% 27
2021
Q4
$20.3M Buy
264,500
+217,500
+463% +$17.3M 1.36% 18
2021
Q3
$3.53M Hold
47,000
0.21% 75
2021
Q2
$3.65M Sell
47,000
-194,354
-81% -$14.5M 0.2% 88
2021
Q1
$17.8M Buy
+241,354
New +$17.8M 0.79% 50
2017
Q4
Sell
-350,661
Closed -$21.4M 142
2017
Q3
$21.4M Sell
350,661
-122,406
-26% -$7.42M 1.44% 25
2017
Q2
$28.9M Buy
473,067
+1,048
+0.2% +$63.8K 2.01% 14
2017
Q1
$28.6M Buy
472,019
+148,501
+46% +$9.01M 1.82% 14
2016
Q4
$18.2M Buy
+323,518
New +$18.9M 1.2% 26
2013
Q4
Sell
-644,939
Closed -$29.3M 222
2013
Q3
$29.3M Buy
644,939
+117,271
+22% +$5.35M 0.91% 35
2013
Q2
$23.4M Buy
+527,668
New +$23.6M 0.78% 32

Other funds holding MRK

Clough Capital Partners's MRK Position: Q3 2024 in Review

Clough Capital Partners sold out of Merck (MRK) in Q3 2024, closing a stake of 129,503 shares — an estimated $16M sold.

Clough Capital Partners first reported a position in MRK in Q2 2013 and held it in 18 quarters. The position peaked at $29.3M in Q3 2013. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Clough Capital Partners reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Clough Capital Partners sold 129,503 Merck shares in Q3 2024, an estimated $16M.
  • Clough Capital Partners first reported a position in Merck in Q2 2013 and held it in 18 quarters.
  • Clough Capital Partners's Merck position peaked at $29.3M in Q3 2013.
  • 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Clough Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.